Moberg to divest Balmex brand to Randob Labs

5 March 2018 - Deborah Wilkes

Archived

Sweden's Moberg Pharma is divesting the Balmex range of nappy rash products in the US to Randob Labs for USD4.25 million plus the inventory value at closing.

Click tags below for more information on topics:

Moberg

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: